证券记录 · 已归档季度
SLDB
Solid Biosciences Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
11.02M持有股份
$40.79M报告持仓市值
+3新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 +30.0% ·
净新建仓位 +9.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | +6 | 45.63M | $455.47M | +9 | −3 |
| Q1 2026 | 69 | 0 | 38.87M | $279.42M | +3 | −3 |
| Q4 2025 | 68 | +2 | 30.07M | $169.59M | +2 | — |
| Q3 2025 | 17 | +1 | 23.96M | $147.82M | +1 | — |
| Q2 2025 | 13 | -1 | 26.02M | $126.70M | +1 | −2 |
| Q1 2025 | 11 | +1 | 11.02M | $40.79M | +3 | −2 |
| Q4 2024 | 10 | -1 | 4.93M | $19.74M | +1 | −2 |
| Q3 2024 | 10 | +1 | 5.36M | $37.37M | +1 | — |
| Q2 2024 | 9 | — | 5.20M | $29.49M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 6.73M | +285.0% | $24.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.89M | +98.8% | $6.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.89M | +98.8% | $6.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 534.56K | -25.7% | $1.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 530.86K | +4.1% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 530.86K | +4.1% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (被动) | 436.28K | +0.9% | $1.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 336.32K | +85.3% | $1.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 336.32K | +85.3% | $1.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 201.42K | 新增 | $745,250 | 0.0% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 175.40K | +112.6% | $648,980 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 113.10K | 新增 | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 113.10K | 新增 | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 113.10K | 新增 | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 113.10K | 新增 | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 113.10K | 新增 | $418,468 | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 69.49K | -49.0% | $257,128 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 11.56K | 新增 | $43,000 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $745,250 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| AQR Capital Management | $418,468 | 0.0% |
| T. Rowe Price | $43,000 | 0.0% |
已清仓
| Wellington Management | $498,204 | 曾为 0.0% |
| D. E. Shaw & Co. | $207,888 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 137 持有人, 96.05M 股份, $689.27M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据